Literature DB >> 9488715

The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation.

O Y So1, L E Scarafia, A Y Mak, O H Callan, D C Swinney.   

Abstract

Prostaglandin H synthases (PGHSs) catalyze the conversion of arachidonic acid to prostaglandins. In this report, we describe the effect of a PGHS2 Y355F mutation on the dynamics of PGHS2 catalysis and inhibition. Tyr355 is part of a hydrogen-bonding network located at the entrance to the cyclooxygenase active site. The Y355F mutant exhibited allosteric activation kinetics in the presence of arachidonic acid that was defined by a curved Eadie-Scatchard plot and a Hill coefficient of 1.36 +/- 0.05. Arachidonic acid-induced allosteric activation has not been directly observed with wild type PGHS2. The mutation also decreased the observed time-dependent inhibition by indomethacin, flurbiprofen, RS-57067, and SC-57666. Detailed kinetic analysis showed that the Y355F mutation decreased the transition state energy associated with slow-binding inhibition (EIdouble dagger) relative to the energy associated with catalysis (ESdouble dagger) by 1.33, 0.67, and 1.06 kcal/mol, respectively, for indomethacin, flurbiprofen, and RS-57067. These observations show Tyr355 to be involved in the molecular mechanism of time-dependent inhibition. We interpret these results to indicate that slow binding inhibitors and the Y355F mutant slow the rate and unmask intrinsic, dynamic events associated with product formation. We hypothesize that the dynamic events are the equilibrium between relaxed and tightened organizations of the hydrogen-bonding network at the entrance to the cyclooxygenase active site. It is these rearrangements that control the rate of substrate binding and ultimately the rate of prostaglandin formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488715     DOI: 10.1074/jbc.273.10.5801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2).

Authors:  R García-Nieto; C Pérez; F Gago
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors.

Authors:  M C Walker; R G Kurumbail; J R Kiefer; K T Moreland; C M Koboldt; P C Isakson; K Seibert; J K Gierse
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.

Authors:  A S Kalgutkar; B C Crews; S W Rowlinson; A B Marnett; K R Kozak; R P Remmel; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  A computational protocol for the integration of the monotopic protein prostaglandin H2 synthase into a phospholipid bilayer.

Authors:  Philip W Fowler; Peter V Coveney
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

5.  Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.

Authors:  Vittorio Limongelli; Massimiliano Bonomi; Luciana Marinelli; Francesco Luigi Gervasio; Andrea Cavalli; Ettore Novellino; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-09       Impact factor: 11.205

6.  The structural basis of endocannabinoid oxygenation by cyclooxygenase-2.

Authors:  Alex J Vecchio; Michael G Malkowski
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

7.  Kinetic basis for selective inhibition of cyclo-oxygenases.

Authors:  J K Gierse; C M Koboldt; M C Walker; K Seibert; P C Isakson
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

8.  Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.

Authors:  Michael C Goodman; Shu Xu; Carol A Rouzer; Surajit Banerjee; Kebreab Ghebreselasie; Marco Migliore; Daniele Piomelli; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2018-01-11       Impact factor: 5.157

9.  Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.

Authors:  Marc Ouellet; Jean-Pierre Falgueyret; M David Percival
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

10.  PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons.

Authors:  Nan Sang; Jian Zhang; Chu Chen
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.